Company Filing History:
Years Active: 2015-2020
Title: Innovations by Inventor Vivian Choi
Introduction
Vivian Choi is a notable inventor based in Waltham, MA (US). She has made significant contributions to the field of retinal research, particularly in the development of viral vectors for the treatment of retinal dystrophy. With a total of 3 patents, her work is paving the way for advancements in gene therapy.
Latest Patents
One of her latest patents focuses on viral vectors that are capable of delivering a heterologous gene to the retina. This invention specifically targets the delivery of RLBP1 to retinal pigment epithelium (RPE) and Müller cells. The patent also encompasses nucleic acids useful for producing these viral vectors, as well as compositions that include the viral vectors. Furthermore, it outlines methods for delivering and expressing a heterologous gene to the retina, which can improve the rate of dark adaptation in subjects and treat RLBP1-associated retinal dystrophy.
Career Highlights
Vivian Choi is currently employed at Novartis AG, where she continues to innovate in the field of retinal treatments. Her work is characterized by a strong focus on gene therapy and its applications in treating retinal diseases.
Collaborations
She has collaborated with notable colleagues such as Chad Eric Bigelow and Thaddeus Peter Dryja, contributing to a rich environment of research and development.
Conclusion
Vivian Choi's contributions to the field of retinal dystrophy treatment through her innovative patents and collaborations highlight her as a key figure in medical research. Her work continues to inspire advancements in gene therapy and improve patient outcomes.